Apply for funding to develop a broad utility, deep genotyping and phenotyping platform capable of generating breakthrough insights into patient response, adverse effects, and resistance to immunotherapy. You must be a researcher employed at a research organisation eligible to apply for Medical research Council (MRC) funding.